A palatinose-based balanced formula improves glucose tolerance, serum free fatty acid levels and body fat composition

Tohoku Journal of Experimental Medicine

Volumn 212, Issue 2, 2007, Pages 91-99

  Oizumi, Toshihide ^a   Daimon, Makoto ^a   Jimbu, Yumi ^a   Kameda, Wataru ^a   Arawaka, Nobuko ^a   Yamaguchi, Hiroshi ^a   Ohnuma, Hiroshi ^a   Sasaki, Hajime ^b   Kato, Takeo ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b MEIJI DAIRIES CORPORATION   (Japan)

Author keywords

Free fatty acid; Glucose tolerance; Metabolic syndrome; Palatinose; Visceral fat area

Indexed keywords

CHOLESTEROL; FATTY ACID; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PALATINOSE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY FAT; BODY HEIGHT; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; ELEMENTAL DIET; FATTY ACID BLOOD LEVEL; FEMALE; FOOD INTAKE; GLUCOSE TOLERANCE; HONEY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INTRAABDOMINAL FAT; MALE; METABOLIC SYNDROME X; ORAL GLUCOSE TOLERANCE TEST; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADIPOSE TISSUE; BLOOD GLUCOSE; CROSS-OVER STUDIES; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; ISOMALTOSE; MALE; MIDDLE AGED;

EID: 34447571659     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.212.91     Document Type: Article

References (29)

1. Arai, H., Mizuno, A., Matsuo, K., Fukaya, M., Sasaki, H., Arima, H., Matsuura, M., Taketani, Y., Doi, T. & Takeda, E. (2004) Effect of a novel palatinose-based liquid balanced formula (MHN-01) on glucose and lipid metabolism in male Sprague-Dawley rats after short- and long-term ingestion. Metabolism, 53, 977-983.
2. Arai, H., Mizuno, A., Sakuma, M., Fukaya, M., Matsuo, K., Muto, K., Sasaki, H., Matsuura, M., Okumura, H., Yamamoto, H., Taketani, Y., Doi, T. & Takeda, E. (2007) Effects of a palatinose-based liquid diet (Inslow) on glycemic control and the second-meal effect in healthy men. Metabolism, 56, 115-121.
3. Bretzel, R.G., Voigt, K. & Schatz, H. (1998) The United Kingdom Prospective Diabetes Study (UKPDS) implications for the pharmacotherapy of type 2 diabetes mellitus. Exp. Clin. Endocrinol. Diabetes, 106, 369-372.
4. Bruce, D.G., Chisholm, D.J., Storlien, L.H. & Kraegen, E.W. (1988) Physiological importance of deficiency in early prandial insulin secretion in non-insulin-dependent diabetes. Diabetes, 37, 736-744.
5. Chiasson, J.L., Josse, R.G., Gomis, R., Hanefeld, M., Karasik, A., Laakso, M. & STOP-NIDDM Trail Research Group (2002) Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet, 259, 2072-2077.
6. Dablquist, A., Auricchio, S., Semenza, G. & Prader, A. (1963) Human intestinal disaccharidases and hereditary disaccharide intolerance: The hydrolysis of sucrose, isomaltose, palatinose (isomaltulose), and 1,6-a-oligosaccharide (isomalto-oligosaccharide) preparation. J. Clin. Invest., 42, 556-562.
7. Eriksson, K.F. & Lindgarde, F. (1998) No excess 12-year mortality in men with impaired glucose tolerance who participated in the Malmo Preventive Trial with diet and exercise. Diabetologia, 41, 1010-1016.
8. Hanefeld, M., Cagatay, M., Petrowitsch, T., Neuser, D., Petzinna, D. & Rupp, M. (2004) Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies. Eur. Heart J., 25, 10-16.
9. Hernan, W.H., Brandle, M., Zhang, P., Williamson, D.F., Matulik, M.J., Ratner, R.E., Lachin, J.M. & Engelgau, M.M. (2003) Diabetes Prevention Program Research Group. Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program. Diabetes Care, 26, 36-47.
10. Jebb, S.A., Cole, T.J., Doman, D., Murgatroyd, P.R. & Prentice, A.M. (2000) Evaluation of the novel Tanita body-fat analyser to measure body composition by comparison with a four-compartment model. Br. J. Nutr., 83, 115-122.
11. Jenkins, D.J., Wolever, T.M., Taylor, R.H., Griffiths, C., Krzeminska, K., Lawrie, J.A., Bennett, C.M., Goff, D.V., Sarson, D.L. & Bloom, S.R. (1982) Slow release dietary carbohydrate improves second meal tolerance. Am. J. Clin. Nutr., 35, 1339-46.
12. Laakso, M. & Lehto, S. (1997) Epidemiology of macrovascular disease in diabetes. J. Diabetes Rev., 5, 294-315.
13. Laedtke, T., Kjems, L., Porksen, N., Schmitz, O., Veldhuis, J., Kao, P.C. & Butler, P.C. (2000) Overnight inhibition of insulin secretion restores pulsatility and proinsulin/insulin ratio in type 2 diabetes. Am. J. Physiol. Endocrinol. Metab., 279, E520-E528.
14. Liljeberg, H.G., Akerberg, A.K. & Bjorck, I.M. (1999) Effect of the glycemic index and content of indigestible carbohydrates of cereal-based breakfast meals on glucose tolerance at lunch in healthy subjects. Am. J. Clin. Nutr., 69, 647-655.
15. Lillioja, S., Mott, D.M., Howard, B.V., Bennett, P.H., Yki-Jarvinen, H., Freymond, D., Nyomba, B.L., Zurlo, F., Swinburn, B. & Bogardus, C. (1988) Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N. Engl. J. Med., 318, 1217-1225.
16. Lina, B.A., Jonker, D. & Kozianowski, G. (2002) Isomaltulose (Palatinose): a review of biological and toxicological studies. Food Chem. Toxicol., 40, 1375-1381.
17. Lingström, P., Lundgren, F., Birkhed, D., Takazoe, I. & Frostell, G. (1997) Effects of frequent mouthrinses with palatinose and xylitol on dental plaque. Eur. J. Oral. Sci., 102, 162-169.
18. Nakagami, T. & the DECODA Study Group (2004) Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin. Diabetologia, 47, 385-394.
19. Oldroyd, J.C., Unwin, N.C., White, M., Imrie, K., Mathers, J.C. & Alberti, K.G. (2001) Randomised controlled trial evaluating the effectiveness of behavioural interventions to modify cardiovascular risk factors in men and women with impaired glucose tolerance: outcomes at 6 months. Diabetes Res. Clin. Pract., 52, 29-43.
20. Reaven, G. & Miller, R. (1968) Study of the relationship between glucose and insulin responses to an oral glucose load in man. Diabetes, 17, 560-569.
21. Ribeiro-Filho, F.F., Faria, A.N., Kohlmann, N.E., Zanella, M.T. & Ferreira, S.R. (2003) Two-hour insulin determination improves the ability of abdominal fat measurement to identify risk for the metabolic syndrome. Diabetes Care, 26, 1725-1730.
22. Risso, A., Mercuri, F., Quagliaro, L., Damante, G. & Ceriello, A. (2001) Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture. Am. J. Physiol. Endocrinol. Metab., 281, E924-E930.
23. Savage, P.J., Bennion, L.J., Flock, E.V., Nagulesparan, M., Mott, D., Roth,.J., Unger, R.H. & Bennett, P.H. (1979) Diet-induced improvement of abnormalities in insulin and glucagon secretion and in insulin receptor binding in diabetes mellitus. J. Clin. Endocrinol. Metab., 48, 999-1007.
24. Siddiqui, I.R. & Furgala, B. (1967) Isolation and characterization of oligosaccharides from honey. Part 1. Disaccharides. J. Api. Res., 6, 139-145.
25. Temelkova-Kurktschiev, T.S., Koehler, C., Henkel, E., Leonhardt, W., Fuecker, K. & Hanefeld, M. (2000) Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care, 23, 1830-1834.
26. Tominaga, M., Eguchi, H., Manaka, H., Igarashi, K., Kato, T. & Sekikawa, A. (1999) Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care, 22, 920-924.
27. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 352, 837-853.
28. Uusitupa, M., Lindi, V., Louheranta, A., Salopuro, T., Lindstrom, J. & Tuomilehto, J. (2003) Finnish Diabetes Prevention Study Group. Long-term improvement in insulin sensitivity by changing lifestyles of people with impaired glucose tolerance: 4-year results from the Finnish Diabetes Prevention Study. Diabetes, 52, 2532-2538.
29. World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Geneva, World Health Organization. (Report of a WHO consultation. Part 1, diagnosis and classification of diabetes Mellitus)